Naloxone reverses opioid overdoses by knocking opioid molecules off the receptors in your brain that control breathing. It works in minutes, and it’s the single most effective tool for preventing opioid overdose deaths. But it has limits: it wears off faster than many opioids, it doesn’t work on non-opioid drugs, and potent synthetics like fentanyl can require multiple doses.
What Happens at the Receptor Level
Opioids, whether prescription painkillers, heroin, or fentanyl, work by binding to specific docking sites on brain cells called mu-opioid receptors. When these receptors are activated, they suppress pain signals and slow breathing. In an overdose, so many receptors are activated that breathing slows to a dangerous crawl or stops entirely.
Naloxone is what pharmacologists call a competitive antagonist. It binds to the same mu-opioid receptors but doesn’t activate them. Instead, it physically displaces the opioid molecules already sitting there, like a key that fits the lock but doesn’t turn it. Because naloxone has a higher affinity for those receptors than most opioids do, it wins the competition for binding space. Within minutes, the opioid’s effects, including the life-threatening suppression of breathing, reverse.
This is also why naloxone has no effect on someone who hasn’t taken opioids. It only blocks opioid receptors, and if nothing is activating those receptors, there’s nothing to reverse. It won’t produce a high, and it has no potential for misuse.
How Fast It Works and How Long It Lasts
Speed depends on the delivery method. An intramuscular injection reaches peak blood levels in roughly 23 minutes. The standard nasal spray (4 mg) peaks at about 30 minutes, with a range of 10 to 60 minutes depending on the person. In practice, people often see signs of reversal, like resumed breathing, well before peak levels are reached.
The more important number is duration. The nasal spray maintains effective blood levels for about 2 hours from a single dose, or up to 3 hours if a second spray is administered in the other nostril. That sounds like a comfortable window, but many opioids last far longer. Methadone, extended-release oxycodone, and fentanyl patches can remain active for many hours. This creates a dangerous gap: naloxone wears off, the opioid is still in the body, and breathing can slow again. This rebound effect, sometimes called renarcotization, is why staying with someone after giving naloxone and calling emergency services is critical.
The Fentanyl Challenge
Fentanyl and its derivatives have made overdose reversal harder. Fentanyl is far more potent than heroin at the receptor level, meaning a smaller amount produces a much stronger effect. Carfentanil, an analog sometimes found in illicit drug supplies, is roughly 100 times more potent than fentanyl itself.
Standard naloxone doses sometimes can’t compete with the sheer concentration of these drugs at the receptor. Reports from emergency medical services describe fentanyl overdoses that don’t respond to nasal naloxone at all, and respond only briefly to intravenous naloxone before the person slips back into respiratory depression. One theory is that when fentanyl floods the bloodstream at very high concentrations, it may saturate the same transport system naloxone needs to cross into the brain, essentially blocking naloxone from getting where it needs to go regardless of dose.
This is why the FDA approved higher-dose naloxone products, including devices delivering 2 mg by injection (five times the original auto-injector dose) and the 4 mg nasal spray that is now available over the counter. If a first dose doesn’t restore breathing within 2 to 3 minutes, a second dose should be given. There is no upper limit to how many doses can be safely administered in an emergency.
What Naloxone Cannot Reverse
Naloxone only works on opioids. If an overdose involves alcohol, benzodiazepines, stimulants, or other non-opioid substances, naloxone will not reverse those effects. This matters increasingly because the illicit drug supply now frequently contains xylazine, a veterinary sedative that suppresses breathing through a completely different mechanism. The CDC notes that naloxone will not reverse the effects of xylazine, but should still be given in any suspected overdose because opioids like fentanyl are almost always present alongside it. The xylazine-related breathing problems may continue even after naloxone restores opioid-blocked breathing, which is one reason emergency medical care remains essential.
Precipitated Withdrawal
When naloxone strips opioids off receptors in someone who is physically dependent, it can trigger immediate withdrawal symptoms. This is called precipitated withdrawal, and it’s uncomfortable but not life-threatening. The most common sign is a rapid heart rate, which shows up in about 80% of cases. Nausea, vomiting, agitation, sweating, and body aches can also appear within minutes.
Precipitated withdrawal is an expected side effect, not a complication. It’s vastly preferable to the alternative of continued respiratory arrest. The symptoms typically fade as the naloxone wears off, though the person may feel unwell for several hours. Some people who experience this discomfort after being revived will want to use opioids again quickly to relieve the withdrawal, which creates its own risk since the naloxone is still partially active and the interaction can be unpredictable.
How to Use the Nasal Spray
The over-the-counter nasal spray (sold under the brand name Narcan, among others) delivers a single 4 mg dose in a 0.1 mL spray. Each device is good for one use. The steps are straightforward: tilt the person’s head back, insert the nozzle into one nostril, and press the plunger firmly. The device does not require any assembly or priming. If there’s no improvement in breathing after 2 to 3 minutes, give a second spray in the other nostril using a new device.
The person should be placed on their side in a recovery position to prevent choking if they vomit, which is common as opioid effects reverse. Even if the person wakes up and seems fine, they need emergency medical attention. The naloxone may wear off before the opioid does.
Safety in Pregnancy and Children
Naloxone can be used in both children and pregnant individuals during an overdose emergency. The nasal spray is approved for pediatric patients at the same 4 mg dose used for adults. In pregnancy, the calculus is simple: an overdose that stops breathing is immediately life-threatening to both the pregnant person and the fetus, and naloxone addresses that threat directly.
That said, naloxone in pregnancy carries specific considerations. Rapid opioid reversal can trigger withdrawal, and it isn’t fully understood how withdrawal affects a developing pregnancy. Studies have not shown an increased chance of birth defects from naloxone use, though one study found a possible association with preterm delivery or low birth weight. Infants born to people who used opioids during pregnancy may develop neonatal abstinence syndrome after birth, with symptoms like irritability, poor feeding, tremors, and excessive crying that typically appear around two days after delivery and can last more than two weeks.